Atrium Therapeutics Inc
RNA
NASDAQ
Biotechnology
$12.84
USD
+0.51 (+4.14%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $209.37M
Volume 176.1K
Price Target
$25.00 – $25.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $25.00 and a min estimate of $25.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$25.00
Unchanged vs prior
Implied Upside
+94.7%
Unchanged vs prior
Analyst Covering
2
Unchanged vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Mitchell S. Kapoor | HC Wainwright & Co. | Buy | Initiated | 1 week ago | Plus | Plus | Plus |
Kristen Kluska | Cantor Fitzgerald | Buy | Initiated | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
NERV
Minerva Neurosciences Inc
$4.58
▲ +16.8%
ORGO
Organogenesis Holdings Inc
$1.79
▲ +1.7%
ALEC
Alector Inc
$1.96
▼ -3.9%
WHWK
Whitehawk Therapeutics Inc
$4.46
▼ -4.7%
NBP
NovaBridge Biosciences
$1.96
▲ +3.2%
IVVD
Invivyd Inc
$0.7200
▲ +5.1%
TNXP
Tonix Pharmaceuticals Holding Corp
$12.71
▲ +1.7%
DTIL
Precision BioSciences Inc
$7.43
▲ +1.8%
IMUX
Immunic Inc
$16.06
▼ -3.1%